Ischemic stroke results in excitotoxicity via hypoxia, glutamate receptor (GluR) overactivation and deregulated calcium homeostasis. Changes in GluR trafficking can occur in response to hypoxia, but the nature of those changes, whether they protect or exacerbate excitotoxicity, remains controversial. Here we examine how hypoxia and the known hypoxia response pathway alter the trafficking of the C. elegans GluR GLR-1. GLR-1 acts in the command interneurons mediating an escape response by triggering reversals in locomotion. Synaptically localized GLR-1 receptors can be observed using a GLR-1::GFP chimeric protein. Recently, we observed a change in GLR-1 trafficking in response to hypoxic treatment: receptors become trapped in internal endosome-like accretions and animals behave similar to
glr-1 knockouts. Loss of function mutations in
egl-9, a prolyl hydroxylase that normally inhibits the cellular response to hypoxia by hydroxylating key proline residues on the transcription factor HIF-1, mimics the effects of hypoxia on GLR-1 trafficking and depresses both glutamate-activated currents and GLR-1- mediated behaviors. HIF-1, the canonical substrate of EGL-9 activity, is not required for this effect; instead, we find that EGL-9 physically interacts with LIN-10, a PTB/PDZ-domain protein that promotes GLR-1 membrane recycling. We find that normal oxygen levels induce a specific EGL-9 isoform to colocalize with LIN-10 in dendrites, where it prevents the phosphorylation of LIN-10 by the proline-directed kinase CDK-5. Un-phosphorylated LIN-10 is recruited to endosomes, where it mediates GLR-1 recycling. By contrast, under hypoxic conditions, EGL-9 is inhibited by lack of oxygen, allowing CDK-5 to inhibit LIN-10 by directly phosphorylating its proline-rich N-terminus. This results in LIN-10 delocalization and the trapping of GLR-1 in endosomes. Mutations in either
cdk-5 or the proline residues of the CDK-5 phosphorylation sites in LIN-10 block the effects of hypoxia and
egl-9 mutations, suggesting a novel kinase regulatory mechanism in which EGL-9 regulates CDK-5 kinase activity by hydroxylating its substrate prolines, thus precluding substrate phosphorylation by CDK-5. We propose that neurons use this novel neuroprotective mechanism to respond to hypoxia by inhibiting receptor membrane recycling so as to reduce GluR synaptic abundance.